Clinical trial
Whole Exome and Transcriptome Sequencing Analysis for the Identification of Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC) - Hellenic Cooperative Oncology Group (HeCOG)
NCT07900581 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Whole Exome and Transcriptome Sequencing Analysis for the Identification of Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC) - Hellenic Cooperative Oncology Group (HeCOG)
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 11, 2021
- Completion date
- December 31, 2026
- Enrollment
- 300 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer (nsclc)
Arms
As registered; 1 arm.
-
Patients with histologically confirmed non-small cell lung.
Patients with histologically confirmed non-small cell lung cancer providing tumor tissue and blood samples for genomic and transcriptomic analyses, including whole-exome sequencing, RNA sequencing, and ctDNA analysis in a subset of patients.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Prevalence of genomic alterations, TMB levels, and mRNA-based immune subtypes
Percentage of Greek NSCLC patients presenting with specific oncogenic drivers, clinically actionable mutations, germline pathogenic/likely pathogenic variants, Tumor Mutational Burden (TMB) signatures, and distinct transcriptomic mRNA-based immune subtypes.
Lead sponsor's other trials
Hellenic Cooperative Oncology Group, most recent start first.
+56 more trials See the organization page
Similar trials
Same condition (Carcinoma, Non-Small-Cell Lung) and phase, most recent start first.
+1,112 more trials See the condition page